Media

TOP NEWS

FEATURED PRESS RELEASE

FEATURED PRESS RELEASE

May 13, 2026

Abeona Therapeutics® Reports First Quarter 2026 Results and Provides Pipeline Update

September 18, 2026

Abeona Therapeutics® Congratulates Ultragenyx on U.S. FDA Approval of FAYUVI™ Gene Therapy for Sanfilippo Syndrome Type A (MPS IIIA)

September 16, 2026

Abeona Therapeutics® Announces Activation of University of Florida Health as Newest Qualified Treatment Center for ZEVASKYN®